Status:
COMPLETED
G-CSF in the Treatment of Toxic Epidermal Necrolysis
Lead Sponsor:
University of Liege
Conditions:
Stevens - Johnson Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
NeupoNET aims to evaluate interest of G-CSF in the treatment of Toxic Epidermal necrolysis. This is a prospective randomized controlled trial. Patients will be allocated in a treatment group (receivi...
Eligibility Criteria
Inclusion
- Toxic epidermal necrolysis with SCORTEN 1 to 5 at admission
Exclusion
- Toxic epidermal necrolysis with SCORTEN 6 or 7 at admission
- Hypercoagulable state
- Cardiac or peripheral arterial disease
- Active malignancy
- Myelodysplastic syndrome or hematological malignancy
- Fructose intolerance
- Pregnancy
- Patient refusal
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02739295
Start Date
July 1 2016
End Date
March 7 2023
Last Update
December 31 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Burn Centre of the University Hospital of Liège
Liège, Belgium, 4000
2
IMTR Burn Centre
Loverval, Belgium